ClinicalTrials.gov
public full text
Public Domain
Pattern Of Use Of Belatacept In US Transplant Recipients
* The prevalence of Belatacept use * The characteristics of Belatacept users and the temporal trends in these characteristics * Characteristics of adult kidney-only transplant recipients who are treated with Belatacept vs. who are treated with Calcineurin inhibitors (CNI)-based regimens at the time of transplantation, and the temporal trends in these characteristics during 7 years post approval of Belatacept.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation#272293
- Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation#363496
- Calcineurin Activity in Renal Recipients#1009837
- Study Evaluating Sirolimus in the Treatment of Kidney Transplant#1009919
- Gene Polymorphisms in Tacrolimus Drug Interactions#979498
Record · ID 894642
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive